HER2 Amplification and Anti-EGFR Sensitivity in Advanced Colorectal Cancer

JAMA Oncol. 2019 May 1;5(5):605-606. doi: 10.1001/jamaoncol.2018.7229.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Colorectal Neoplasms / blood
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / metabolism
  • Drug Resistance, Neoplasm*
  • ErbB Receptors / antagonists & inhibitors
  • Humans
  • Progression-Free Survival
  • Protein Kinase Inhibitors / therapeutic use*
  • Receptor, ErbB-2 / antagonists & inhibitors
  • Receptor, ErbB-2 / blood
  • Receptor, ErbB-2 / metabolism*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • EGFR protein, human
  • ERBB2 protein, human
  • ErbB Receptors
  • Receptor, ErbB-2